Dr. Vineet Chopra Will Step Down as Department Chair
Dr. Vineet Chopra will transition from his leadership role at the University of Colorado Anschutz School of Medicine on October 26.
Updated on Oct. 12, 2026 in People
Live Poll
Should your local university prioritize research funding growth as a primary measure of departmental success?
Dr. Vineet Chopra will step down as chair of the University of Colorado Anschutz School of Medicine department on October 26, 2026. He will continue to serve as the executive vice dean for clinical, quality, and research.
Why it matters
The change follows a tenure marked by significant departmental growth in funding and the expansion of data-driven processes for faculty reviews and clinical performance. Mark Earnest will step in to serve as the interim chair.
The department currently supports 192 residents and 200 fellows while handling over 1 million annual patient visits. Research funding in 2025 included $89 million in federal support and total research awards of $162 million.
The players
Dr. Vineet Chopra
He is the outgoing chair of the University of Colorado Anschutz School of Medicine department and executive vice dean for clinical, quality, and research.
Mark Earnest
He is the incoming interim chair of the Department of Medicine who will take over leadership duties from Dr. Chopra.
University of Colorado Anschutz School of Medicine
This institution is a major academic medical center located in Aurora that conducts extensive clinical research and training for residents and fellows.
The details
During his leadership, the department increased investment in research and researchers fivefold over a five-year period. The school also implemented new data-focused strategies to manage salary equity and annual faculty promotion processes.
Timeline
May 2025: Dr. Chopra was appointed as interim executive vice dean.
2025: Department faculty received $162 million in research awards.
October 26, 2026: Dr. Chopra will step down as department chair.
Market Landscape
The transition follows a period of rapid departmental growth marked by the 2025 research award expansion. This leadership shift aims to maintain the current trajectory of the school as it continues to improve its national standing in NIH funding.
The transition in leadership is not expected to disrupt ongoing clinical operations or the care provided to patients during their annual visits. Residents and fellows currently supported by the department will continue their training under the incoming interim leadership.
The takeaway
The transition marks a strategic pivot for the department as it seeks to maintain its recent gains in federal funding and research output. Staff and stakeholders should look for updates from the interim chair regarding upcoming departmental priorities.
Further reading
For more on personnel changes in the local medical sector, visit the People section.
Source note: This article includes information reported by The American Bazaar.
Live Poll
Should your local university prioritize research funding growth as a primary measure of departmental success?
